Tryptophan metabolism determines outcome in tuberculous meningitis: a targeted metabolomic analysis

Background Cellular metabolism is critical for the host immune function against pathogens, and metabolomic analysis may help understand the characteristic immunopathology of tuberculosis. We performed targeted metabolomic analyses in a large cohort of patients with tuberculous meningitis (TBM), the most severe manifestation of tuberculosis, focusing on tryptophan metabolism. Methods We studied 1069 Indonesian and Vietnamese adults with TBM (26.6% HIV-positive), 54 non-infectious controls, 50 with bacterial meningitis, and 60 with cryptococcal meningitis. Tryptophan and downstream metabolites were measured in cerebrospinal fluid (CSF) and plasma using targeted liquid chromatography mass-spectrometry. Individual metabolite levels were associated with survival, clinical parameters, CSF bacterial load and 92 CSF inflammatory proteins. Results CSF tryptophan was associated with 60-day mortality from tuberculous meningitis (HR=1.16, 95%CI=1.10–1.24, for each doubling in CSF tryptophan) both in HIV-negative and HIV-positive patients. CSF tryptophan concentrations did not correlate with CSF bacterial load nor CSF inflammation but were negatively correlated with CSF interferon-gamma concentrations. Unlike tryptophan, CSF concentrations of an intercorrelating cluster of downstream kynurenine metabolites did not predict mortality. These CSF kynurenine metabolites did however correlate with CSF inflammation and markers of blood-CSF leakage, and plasma kynurenine predicted death (HR 1.54, 95%CI=1.22–1.93). These findings were mostly specific for TBM, although high CSF tryptophan was also associated with mortality from cryptococcal meningitis. Conclusion TBM patients with a high baseline CSF tryptophan or high systemic (plasma) kynurenine are at increased risk of mortality. These findings may reveal new targets for host-directed therapy.


67
Tuberculous meningitis (TBM) is the most severe manifestation of tuberculosis affecting approximately 68 160,000 adults each year. 1 Patients suffer from varying degrees of intracerebral inflammation, commonly 69 manifest as leptomeningitis, vasculitis and space-occupying brain lesions (tuberculomas). Hydrocephalus, 70 stroke, seizures, focal neurological deficits, and loss of consciousness are common complications and lead to 71 death in around 30% of patients, even when treated with anti-tuberculosis drugs and adjuvant corticosteroid 72 therapy. 1 Development of more effective host-directed therapy is hampered by a lack of knowledge on the 73 biological pathways involved in the immunopathology of TBM. 2 74 Metabolism is critical for the function of immune cells, and analysis of cerebrospinal fluid (CSF) metabolites 75 could help unravel underlying biological mechanisms in TBM. Previously, using a large-scale metabolomics 76 analysis, we found that lower cerebrospinal fluid (CSF) tryptophan concentrations were associated with 77 survival of TBM patients in Indonesia. 3 This study did not include HIV-infected patients and the association was 78 not validated in other populations. 4,5 Moreover, there is a need to investigate the downstream metabolites in 79 the kynurenine pathway (Figure 1), through which 95% of tryptophan is initially catabolized via indoleamine 80 2,3-dioxygenase (IDO) or tryptophan 2,3-dioxygenase (TDO) and which includes metabolites with putative 81 neuroprotective (e.g. kynurenic acid) or neurodamaging (e.g. quinolinic acid) properties. 6 Lastly, there is a 82 need to compare these findings in other neuro-infectious diseases to distinguish disease specific from broader 83 mechanisms. 84 We therefore sought to define and validate the relationship between tryptophan and its metabolites and 85 survival from TBM in large, independent populations, including HIV-positive individuals. We aimed to confirm 86 that a higher CSF tryptophan would predict higher mortality across different populations and we hypothesized 87 that high tryptophan would be associated with a higher CSF bacterial load, more inflammation and lower 88 downstream kynurenine metabolites. We lastly sought to investigate how systemic (plasma) metabolite 89 concentrations linked to outcome. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023.  is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint Peak abundances were manually integrated using the MassHunter software provided by the LC-MS 151 manufacturer. 152

CSF mycobacterial load and inflammatory proteins 153
The CSF mycobacterial load was inferred qualitatively by comparing patients with negative versus positive CSF 154 culture, and semiquantitively from the GeneXpert Ct-values as described previously, 10  analyses between metabolites levels, and between metabolites levels and clinical and inflammatory 171 parameters, were calculated using spearman-rank correlation. The impact of baseline CSF and plasma 172 metabolite levels on 60-day survival was tested in a Cox-regression model, adjusted for sex, age, and HIV 173 status as covariates. The model stratified by study site as mortality is known to be higher in the Indonesian 5 174 than in the Vietnamese 7 cohort. An analysis plan was made before the study, and correction for multiple 175 testing using the Benjamini Hochberg method was done if multiple comparisons were done in primary 176 analysis. 177 178 179 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Baseline characteristics of TBM patients and controls 181
We studied 1069 adults with TBM, 390 from Indonesia and 679 from Vietnam ( Table 1). Patients were young 182 (median age 34 years), 26.6% were HIV-positive, and the majority presented with a moderately severe (55.6 % 183 grade II) to severe (17.0% grade III) severe disease according to the international classification. 14 The rate of 184 mycobacterial confirmation was 64.1%. Sixty-day mortality, the primary endpoint in the analysis, was 21.6%. 185 Patients who died within 180 days from admission did so after a median of 14 days. A 14-day cut-off was 186 therefore used to distinguish early from late mortality as a secondary endpoint. 187 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. There were some differences between the populations. Indonesian patients presented with more severe 192 diseases (91.9% grade with grade II or III) than Vietnamese patients (62.2%). Also, CSF total protein, a proxy for 193 blood-CSF barrier leakage, 12 was higher in Indonesian (median=1.6 g/L, IQR=0.8-3.1) than Vietnamese   Figure 3), as reported previously. 4,5 Baseline CSF tryptophan was associated with 210 both early (HR=1.14, 95%CI=1.06-1.23) and late (HR=1.17, 95%CI=1.08-1.26) mortality (Supplementary Table  211 1). Compared to non-infectious controls, CSF tryptophan was lower. This was also observed in patients with 212 cryptococcal, but not in those with bacterial meningitis (Figure 3). Interestingly, among 17 cryptococcal 213 meningitis patients with available in-hospital mortality data in Indonesia, baseline CSF tryptophan was 214 significantly higher in those who died in hospital compared to those discharged alive (Supplementary Figure  215  4 is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Relationship between cerebral and systemic metabolism and its impact on survival 239
Ninety-five percent of tryptophan is converted to kynurenine 6 and we therefore hypothesized that lower CSF 240 tryptophan levels in TBM are caused by higher conversion to kynurenine, and that the higher CSF tryptophan 241 associated with death could reflect reduced activity of IDO1 and other downstream enzymes. CSF kynurenine 242 (Figure 3) and its downstream metabolite kynurenic acid (Supplementary Figure 6) were higher in TBM 243 patients, bacterial meningitis and cryptococcal meningitis patients compared to non-infectious controls, but 244 not significantly different between surviving and non-surviving TBM patients ( Table 2). 245 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint concentrations of CSF metabolites with those in plasma, measured in a subset of 300 TBM patients. In contrast 252 to our findings in CSF, plasma tryptophan levels were higher and kynurenine levels were lower in TBM patients 253 compared to controls. As the CSF kynurenine metabolites positively correlated with CSF protein (Figure 4), a 254 proxy for barrier leakage 12 , we hypothesized that systemic leakage might be an additional source of 255 kynurenine. For a subset of metabolites, absolute quantification of metabolite levels was achieved. This 256 showed that the increase in CSF kynurenine in TBM patients (Δ = 3.52 µM) was much more marked than the 257 decrease in CSF tryptophan (Δ = 0.39 µM, Figure 3B). Corroborating our leakage hypothesis, the CSF-plasma 258 gradient of the kynurenine metabolites showed strong correlations with total CSF protein (Supplementary 259 Figure 7). Plasma tryptophan did not predict mortality, but plasma levels of its downstream metabolites 260 kynurenine strongly predicted mortality (Supplementary Table 2). 261 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint 262 CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

CSF tryptophan is inversely correlated with interferon-gamma 268
We next looked at correlations of tryptophan metabolites and inflammation, as inflammation is a determinant 269 of outcome from TBM. 2 Out of 92 inflammatory proteins measured in CSF from 176 TBM patients from 270 Indonesia, 80 proteins were detectable in >75% of patients. Tryptophan correlated inversely to a small cluster 271 of 13 cytokines, including interferon gamma (IFN-γ, Supplementary Figure 8). In line with this finding, a higher 272 CSF IFN-γ has previously been shown to predict survival of Vietnamese TBM patients. 4 IFN-γ is known to induce 273 IDO1 15 , which converts tryptophan to kynurenine. We indeed confirmed the inverse correlation between CSF 274 tryptophan and IFN-γ in our Vietnamese patients (Spearman's rho=-0.45, p<0.0001, Figure 5A), irrespective of 275 HIV-status. Different from tryptophan, the kynurenine metabolites (kynurenine, kynurenic acid, 3-276 hydroxyanthranilic acid, and quinolinic acid) correlated strongly with a large cluster of inflammatory proteins 277 including the hallmark inflammatory protein TNF-⍺, which we could again confirm in the Vietnamese patients 278 (Spearman's rho=0.30, p<0.0001, Figure 5B). 279 280 281 CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint Discussion 289 We previously found that CSF concentrations of tryptophan were lower in HIV-negative Indonesian adults with 290 TBM compared to non-infectious controls, and that TBM patients with lower tryptophan levels had lower 291 mortality. 3 In the current study we confirm these observations in a much larger cohort of HIV-negative and 292 positive patients from both Vietnam and Indonesia. Aiming to understand how tryptophan metabolism is 293 altered in TBM and how it might exert its effect on patient outcome, we correlated its concentrations with 294 bacterial load and CSF inflammatory markers and measured downstream metabolites both in CSF and plasma. 295 Our findings show that CSF concentrations of downstream kynurenine metabolites did not predict mortality, 296 and that higher tryptophan levels were not associated with a higher bacterial load. Also, while kynurenine 297 metabolites strongly correlated with CSF inflammatory markers and CSF protein, a marker of blood-CSF 298 leakage, there was no association with CSF tryptophan. A higher tryptophan did however show a strong 299 negative correlation with IFN-γ, important for immunity against mycobacteria. Collectively, these findings 300 suggest that tryptophan affects outcome from TBM within the brain rather than systemically. This is 301 potentially driven by IFN-γ but not associated with nonspecific inflammation, and independent from 302 downstream tryptophan metabolism or bacterial replication. In contrast, kynurenine may affect outcome 303 systemically by leakage across the blood-brain barrier. 304 CSF tryptophan increases with age in individuals without central nervous system infections. 16 Age is known to 305 negatively impact outcome of TBM 4,5 and in this study, higher age was associated with higher CSF tryptophan 306 concentrations. All mortality analyses were therefore corrected for age, as well as sex and HIV-status, and 307 analysis was stratified for country because of the overall higher mortality in Indonesian compared to 308 Vietnamese tuberculous meningitis patients. 4,5 We further tested whether higher CSF tryptophan reflected a 309 higher mycobacterial burden and refuted this hypothesis. For cryptococcal meningitis, no previous data on 310 cerebral tryptophan metabolism was known. These patients follow a pattern similar to TBM, with low 311 tryptophan and high kynurenine, and in a small number of cryptococcal meningitis patients, a high baseline 312 CSF tryptophan predicted mortality, similar ss for TBM. 313 Systemic tryptophan and kynurenine are transported into the brain over the large amino acid transporter 314 LAT1. In a healthy brain, systemic and CSF kynurenine positively correlate, as do CSF concentrations of 315 tryptophan and kynurenine. 16 In patients with cerebral inflammation, the correlation between CSF kynurenine 316 and tryptophan can be lost, probably through increased catabolism through IDO upregulation, which also has 317 been demonstrated in the brain parenchyma of deceased TBM patients. 18 Although we found low CSF 318 tryptophan and high CSF kynurenine in TBM compared to healthy controls, the two did not intercorrelate and 319 moreover, the increase in CSF kynurenine was much larger than the decrease in CSF tryptophan and it is 320 therefore unlikely that upregulation of IDO1 solely explains this which precludes catabolism as the sole 321 explanation. This suggests that increased blood to central nervous system transport as an additional 322 mechanism to IDO1 upregulation. Endothelial cells and pericytes of the blood-brain-barrier can upregulate 323 tryptophan catabolism into kynurenine metabolites upon IFN-γ stimulation. 19 Our findings corroborate this 324 hypothesis because we find a strong negative correlation between CSF IFN-γ and CSF tryptophan in our 325 patients. 326 We examined whether higher CSF tryptophan concentrations reflected higher concentrations of downstream 327 kynurenine metabolites that may have neurotoxic (quinolinic acid) or lower levels of the metabolites that may 328 have neuroprotective (kynurenic acid) properties 6 and refuted these hypotheses. Interestingly however, CSF 329 kynurenine metabolites correlated with CSF cell counts and pro-inflammatory proteins, including TNF-⍺. 330 Kynurenine is sensed by the aryl hydrocarbon receptor (AhR), which is important for the upregulation of TNF 331 among other pro-inflammatory cytokines in a mouse model, 20 in line with our CSF findings. The increased CSF 332 kynurenine levels we found in TBM have been reported before in bacterial meningitis 21,22 and in cerebral 333 malaria 23 and in plasma from pulmonary TB patients. 17 Of interest, nicotinamide can inhibit M. tuberculosis 334 growth, and can compete with isoniazid for antimycobacterial effects. 24 We did however not find a 335 detrimental effect of a higher nicotinamide, possibly because of its complex biology, i.e. it can also be 336 produced by M. tuberculosis when human dietary niacin intake is limited. 25 337 Strengths of our study include the large numbers of clinically well-phenotyped patients from multiple 338 independent study sites in Indonesia and Vietnam, including a significant proportion of HIV-positive patients. 339 We moreover used a sensitive triple quadrupole (QQQ) mass spectrometry method specifically designed to 340 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint accurately target the tryptophan metabolites. Absolute quantification of a subset of metabolites further 341 facilitated interpretation. Due to differences in polarity of the downstream tryptophan metabolites, we could 342 not measure the complete tryptophan pathway. The availability of CSF at baseline only, limits our ability to 343 understand how changes in tryptophan metabolism influence mortality. And we infer our observations from 344 lumbar CSF, which reflects biological processes from both the blood and the brain. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint 430 431 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

(which was not certified by peer review)
The copyright holder for this preprint this version posted January 9, 2023. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.

Supplementary Figure 7 Associations between CSF/plasma metabolite ratios (y-axis) and CSF protein levels 480 (as a proxy of CSF barrier leakage, x-axis). Of note, 71 patients had undetectable plasma levels of 3-481
indolacetic acid and were removed from this graph. 482 483 484 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 9, 2023. CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 9, 2023. Hochberg correction for multiple testing. 504 . CC-BY 4.0 International license It is made available under a is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) The copyright holder for this preprint this version posted January 9, 2023. ; https://doi.org/10.1101/2023.01.08.23284316 doi: medRxiv preprint